Progress
Quantity
19317
Indian Army announces a tender for Silver Sulphadiazine 1 Ointment 20 gm tube, Nortriptyline 25 mg Tab, Ipratropium Bromide Respirator soln 500 mcg 2 ml respule, Linctus Cough Paediatric, Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg, Levo Salbutamol Sulphate, 2. 5 ml, containing 1. 25 mg, Respule, Tiotropium Bromide 9 mcg, 120 metered doses unit, Inhaler, Syp Zinc 20 mg 5 ml bottle of 100 ml, Anti haemorhoidal Ointment containing Betamethasone, Syp Montelukast Levocetrizine, Common Cold Tab, Naproxen 250mg Tab in TINSUKIA, ASSAM. Quantity: 19317. Submission Deadline: 06-01-2025 11: 00: 00. Last date to apply is approaching fast!
Tender Category
Goods
Bid To RA
No
Item Category
Silver Sulphadiazine 1 Ointment 20 gm tube , Nortriptyline 25 mg Tab , Ipratropium Bromide Respirator soln 500 mcg 2 ml respule , Linctus Cough Paediatric , Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg , Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule , Tiotropium Bromide 9 mcg, 120 metered doses unit, Inhaler , Syp Zinc 20 mg 5 ml bottle of 100 ml , Anti haemorhoidal Ointment containing Betamethasone , Syp Montelukast Levocetrizine , Common Cold Tab , Naproxen 250mg Tab
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Silver Sulphadiazine 1 Ointment 20 gm tube
Silver Sulphadiazine 1% Ointment 20 gm tube
Nortriptyline 25 mg Tab
Nortriptyline 25 mg Tab
Ipratropium Bromide Respirator soln 500 mcg 2 ml respule
Ipratropium Bromide Respirator soln 500 mcg/2 ml respule
Linctus Cough Paediatric
Linctus Cough Paediatric
Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg
Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI (Aerocort)
Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule
Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule
Tiotropium Bromide 9 mcg, 120 metered doses unit, Inhaler
Tiotropium Bromide 9 mcg, 120 metered doses/unit, Inhaler
Syp Zinc 20 mg 5 ml bottle of 100 ml
Syp Zinc 20 mg/5 ml, bottle of 100 ml
Anti haemorhoidal Ointment containing Betamethasone
Anti haemorhoidal Ointment containing Betamethasone 0.05%, Phenylephrine 0.1% & Lignocaine 2.5%, tube of 15 gm with applicator
Syp Montelukast Levocetrizine
Syp Montelukast+ Levocetrizine
Common Cold Tab
Common Cold Tab (Cetirizine 5-10 mg + Paracetamol 500 mg + Pseudoephedrine 30-60 mg)
Naproxen 250mg Tab
Naproxen 250mg Tab
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Silver Sulphadiazine 1 Ointment 20 gm tube | Silver Sulphadiazine 1% Ointment 20 gm tube | 111 | tube | [email protected] | 21 | |
| 2 | Nortriptyline 25 mg Tab | Nortriptyline 25 mg Tab | 1,200 | no | [email protected] | 21 | |
| 3 | Ipratropium Bromide Respirator soln 500 mcg 2 ml respule | Ipratropium Bromide Respirator soln 500 mcg/2 ml respule | 90 | no | [email protected] | 21 | |
| 4 | Linctus Cough Paediatric | Linctus Cough Paediatric | 180 | bott | [email protected] | 21 | |
| 5 | Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg | Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI (Aerocort) | 10 | no | [email protected] | 21 | |
| 6 | Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule | Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule | 300 | amp vial | [email protected] | 21 | |
| 7 | Tiotropium Bromide 9 mcg, 120 metered doses unit, Inhaler | Tiotropium Bromide 9 mcg, 120 metered doses/unit, Inhaler | 6 | no | [email protected] | 21 | |
| 8 | Syp Zinc 20 mg 5 ml bottle of 100 ml | Syp Zinc 20 mg/5 ml, bottle of 100 ml | 30 | bott | [email protected] | 21 | |
| 9 | Anti haemorhoidal Ointment containing Betamethasone | Anti haemorhoidal Ointment containing Betamethasone 0.05%, Phenylephrine 0.1% & Lignocaine 2.5%, tube of 15 gm with applicator | 150 | tube | [email protected] | 21 | |
| 10 | Syp Montelukast Levocetrizine | Syp Montelukast+ Levocetrizine | 240 | bott | [email protected] | 21 | |
| 11 | Common Cold Tab | Common Cold Tab (Cetirizine 5-10 mg + Paracetamol 500 mg + Pseudoephedrine 30-60 mg) | 15,000 | no | [email protected] | 21 | |
| 12 | Naproxen 250mg Tab | Naproxen 250mg Tab | 2,000 | no | [email protected] | 21 |
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | B LAL & SONS Under PMA | - | 02-01-2025 14:52:49 | |
| 2 | RADIANT PHARMACHEM Under PMA | - | 05-01-2025 22:35:14 | |
| 3 | SUNIL PHARMACY Under PMA | - | 04-01-2025 18:01:38 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | SUNIL PHARMACY(MSE)( MSE Social Category:General ) Under PMA | Item Categories : Silver Sulphadiazine 1 Ointment 20 gm tube,Nortriptyline 25 mg Tab,Ipratropium Bromide Respirator s | |
| L2 | B LAL & SONS (MSE)( MSE Social Category:General ) Under PMA | Item Categories : Silver Sulphadiazine 1 Ointment 20 gm tube,Nortriptyline 25 mg Tab,Ipratropium Bromide Respirator s | |
| L3 | RADIANT PHARMACHEM (MSE)( MSE Social Category:General ) Under PMA | Item Categories : Silver Sulphadiazine 1 Ointment 20 gm tube,Nortriptyline 25 mg Tab,Ipratropium Bromide Respirator s |
Key insights about ASSAM tender market
The eligibility requirements encompass being a registered entity with a valid business license. Bidders must demonstrate compliance with quality and technical specifications relevant to the drugs required. Moreover, Micro, Small, and Medium Enterprises (MSEs) and Startups may be exempt from certain criteria related to experience and turnover if they fulfill the necessary quality standards.
Bidders are required to submit various documents, including proof of registration, quality certifications for the drugs proposed, past performance records, and OEM authorizations if applicable. Additionally, any bids claiming exemptions under the MSE or Startup categories must include supporting documents to justify eligibility.
The registration process involves submitting your organization’s documents through the designated e-procurement portal, including all necessary certifications and proof of previous performance. Follow the steps outlined in the tender documents to complete your registration effectively, ensuring that all submissions align with the tender requirements.
Accepted document formats for submission typically include PDF, DOCX, and any other formats specified in the tender documentation. Bidders must ensure that all documents are clear, legible, and appropriately labeled as per the submission guidelines provided in the tender.
Yes, all submissions must comply with established quality standards applicable to pharmaceutical products. Bidders must demonstrate their capability to meet these standards through the submission of relevant certifications and compliance reports during the evaluation phase.
Bidders must comply with all specifications outlined in the tender documents, which include adherence to quality standards and provisions set forth by regulatory bodies. Successful compliance will be assessed during the technical evaluation of bids.
The products supplied under this tender will be subject to rigorous testing as outlined in the technical specifications provided within the tender. Additional testing criteria related to the efficacy and safety of the pharmaceutical products may also be specified.
The Earnest Money Deposit (EMD) serves as a security measure for the process, ensuring bidder commitment. The specified EMD amount must accompany the bid submission, and details will be provided in the tender documents outlining the amount and submission process.
Successful bidders may be required to provide a performance security, guaranteeing the fulfillment of contract obligations as specified in the bid. The amount and duration will be detailed in the tender documentation.
Payments will adhere to standard government protocols, typically processed post-delivery and quality assessment of the products supplied. Specific payment terms will be established in the contract awarded post evaluation.
The price evaluation will consider the total bid value, with special conditions applying to MSEs. The evaluation aims to ensure competitive pricing alongside compliance with technical specifications.
Bidders must submit their proposals electronically through the designated government e-procurement platform as stated in the tender guidelines. Physical submissions may not be accepted.
Key deadlines, including submission and opening of bids, will be specified in the tender documents. Timelines for bid evaluation and award recommendations will also be outlined to ensure efficient processing.
Results of the evaluation and selection process will typically be communicated via email or through updates on the procurement portal. All participating bidders are advised to remain vigilant for notifications following the bid evaluation.
MSEs are afforded several benefits, including exemptions from specific experience and turnover criteria, subject to meeting quality standards. Furthermore, MSEs will receive preference during the evaluation process if their bids are competitive.
Startups can benefit from similar exemptions as MSEs regarding experience and turnover, promoting engagement in this tender. Compliance with the specified quality standards is necessary for eligibility.
Yes, compliance with 'Make in India' policies may be encouraged, promoting domestic manufacturing. It is essential for bidders to ensure their proposals qualify under these policies when applicable.
Local content and procurement rules are established to promote local manufacturing and supply. Bidders are advised to consult the relevant guidance documents for specific implications on this tender.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS